Aminocoumarins inhibit osteoclast differentiation and bone resorption via downregulation of nuclear factor of activated T cells c1.

doi:10.1016/j.bcp.2012.10.022

Paper

Aminocoumarins inhibit osteoclast differentiation and bone resorption via downregulation of nuclear factor of activated T cells c1.

Published Feb 1, 2013 · Ting Zheng, A Long Sae Mi Noh, Hyojung Park

Biochemical pharmacology

Q1 SJR score

4

Citations

0

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

In Vitro Study

Study Snapshot

Aminocoumarins inhibit osteoclast formation and bone resorption, offering potential therapeutic strategies for treating bone-destructive diseases.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Aminocoumarins inhibit osteoclast differentiation and bone resorption via downregulation of nuclear factor of activated T cells c1.

References

Citations